These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 32207237)

  • 21. Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic literature review.
    Reddy AJ; George ES; Roberts SK; Tierney AC
    Nutr Rev; 2019 Nov; 77(11):765-786. PubMed ID: 31361003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.
    Rinaldi R; De Nucci S; Castellana F; Di Chito M; Giannuzzi V; Shahini E; Zupo R; Lampignano L; Piazzolla G; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there an 'ideal' diet for patients with NAFLD?
    Pugliese N; Plaz Torres MC; Petta S; Valenti L; Giannini EG; Aghemo A
    Eur J Clin Invest; 2022 Mar; 52(3):e13659. PubMed ID: 34309833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketogenic diet for epilepsy and obesity: Is it the same?
    Tagliabue A; Armeno M; Berk KA; Guglielmetti M; Ferraris C; Olieman J; van der Louw E
    Nutr Metab Cardiovasc Dis; 2024 Mar; 34(3):581-589. PubMed ID: 38326186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease.
    Himoto T; Miyatake K; Maeba T; Masaki T
    Can J Gastroenterol Hepatol; 2020; 2020():3576974. PubMed ID: 32695733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the Link between Ketogenic Diet, NAFLD, Mitochondria, and Oxidative Stress: A Narrative Review.
    Paoli A; Cerullo G
    Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
    Eslamparast T; Tandon P; Raman M
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?
    Sofi F; Casini A
    World J Gastroenterol; 2014 Jun; 20(23):7339-46. PubMed ID: 24966604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Kim Y; Chang Y; Kwon MJ; Hong YS; Kim MK; Sohn W; Cho YK; Shin H; Wild SH; Byrne CD; Ryu S
    Am J Gastroenterol; 2021 Nov; 116(11):2270-2278. PubMed ID: 34114568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ketogenic Diet and Alzheimer's Disease.
    Hersant H; Grossberg G
    J Nutr Health Aging; 2022; 26(6):606-614. PubMed ID: 35718870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.
    Worm N
    Nutrients; 2020 May; 12(5):. PubMed ID: 32384593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.
    Muyyarikkandy MS; McLeod M; Maguire M; Mahar R; Kattapuram N; Zhang C; Surugihalli C; Muralidaran V; Vavilikolanu K; Mathews CE; Merritt ME; Sunny NE
    FASEB J; 2020 Nov; 34(11):14832-14849. PubMed ID: 32918763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial.
    Dashti F; Alavian SM; Sohrabpour AA; Mousavi SE; Keshavarz SA; Esmaillzadeh A
    BMJ Open; 2023 Apr; 13(4):e063988. PubMed ID: 37117000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementation with medium-chain fatty acids increases body weight loss during very low-calorie ketogenic diet: a retrospective analysis in a real-life setting.
    Vetrani C; Verde L; Savastano S; Colao A; Muscogiuri G; Barrea L
    J Transl Med; 2023 Jan; 21(1):29. PubMed ID: 36647097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity.
    De Nucci S; Bonfiglio C; Donvito R; Di Chito M; Cerabino N; Rinaldi R; Sila A; Shahini E; Giannuzzi V; Pesole PL; Coletta S; Lanzilotta E; Piazzolla G; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease.
    Perdomo CM; Frühbeck G; Escalada J
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30901929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease.
    Mitsinikos FT; Chac D; Schillingford N; DePaolo RW
    Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 32816619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in Hepatic Lipid Metabolism, and their Relation to Dietary Macronutrients in Pediatric Nonalcoholic Fatty Liver Disease.
    St-Jules DE; Watters CA
    Drug Metab Lett; 2015; 9(2):72-9. PubMed ID: 26343136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.